The Valley Desk

NCT00141297 · Interventional trial

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer

Overall registry status Completed

Phase 1

Conditions Lymphoma, Non-Hodgkin, Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov